The activation of membrane-bound transcription factors involves release from the membrane by proteolysis. Recent studies show that, for some proteins, cleavage is performed by the proteasome, whereas others require specific proteases. Address An additional mechanism of regulation is through subcellular localization. Transcription factors can be rendered inactive by sequestration away from their DNA targets by attachment to structures within the cell such as cytoplasmic membranes. Membrane-bound transcription factors have now been found in organisms as diverse as humans [4] and bacteria [5] . This dispatch deals with two issues. The first is how membrane-bound transcription factors are activated, in particular in light of recent findings regarding the activation of the transmembrane protein and transcription factor Spt23p [6]. The second issue is how this activation is regulated.
The regulation of gene transcription is one of several mechanisms used by cells to respond to alterations in their internal or external environment. To secure a rapid response, transcriptional regulators are often synthesized and stored in an inactive state, becoming active only in response to the appropriate environmental signal. Much of the biological interest in transcriptional responses focuses on how the activity of transcription factors is regulated.
The inactive state of transcription factors can be maintained by a number of different mechanisms. Their activity can be inhibited through interactions with other factors, as in the case of Gal80p inhibiting Gal4p in yeast [1] , or IκB inhibiting NFκB in mammalian cells. Other transcription factors, such as the glucocorticoid receptor, have to associate with non-protein ligands to be able to translocate to the nucleus. Alternatively, transcription factors can be subject to covalent modification, as is the case of the phosphorylation of yeast Pho4p [2] or the acetylation of human p53 [3] .
An additional mechanism of regulation is through subcellular localization. Transcription factors can be rendered inactive by sequestration away from their DNA targets by attachment to structures within the cell such as cytoplasmic membranes. Membrane-bound transcription factors have now been found in organisms as diverse as humans [4] and bacteria [5] . This dispatch deals with two issues. The first is how membrane-bound transcription factors are activated, in particular in light of recent findings regarding the activation of the transmembrane protein and transcription factor Spt23p [6] . The second issue is how this activation is regulated.
SREBPs: membrane-bound transcription factors
The best understood membrane-bound transcription factors to date are the mammalian sterol response element binding proteins, or SREBPs, which play a key role in coordinating a cell's need for cholesterol with its synthesis of cholesterol [7] . The SREBPs are transcriptional regulators of the basichelix-loop-helix leucine zipper family, which activate transcription of genes involved in sterol and fatty acid synthesis. In cells with an adequate supply of cholesterol, the SREBPs are attached to the endoplasmic reticulum (ER) membrane by two transmembrane spans, such that the amino-terminal and carboxy-terminal domains both face the cytoplasm. The amino-terminal region of the SREBPs contains the transcriptional activation domain, whereas the carboxy-terminal region of the SREBPs forms a complex with the SREBP cleavage activating protein, or SCAP.
SCAP is an integral membrane protein with eight membrane-spanning regions that function as a sterolsensing domain. SCAP itself does not cleave the SREBPs, but rather it shuttles the SREBPs from the ER to the Golgi in response to the need for additional sterol synthesis, presumably measured by its intrinsic sterol sensor [8] .
In the Golgi, the SREBPs encounter a dedicated membrane-bound protease called Site 1 protease (S1P), which cleaves the SREBPs between their two transmembrane spans. The SREBPs are then cleaved a second time by a protease called Site 2 protease (S2P). Surprisingly, the second proteolytic cleavage actually takes place inside the first transmembrane span. However, the cleavage site is close enough to the membrane surface to liberate the amino-terminal fragment from the membrane. The transcriptionally active amino-terminal domains of the SREBPs then translocate to the nucleus where they activate transcription of their target genes.
Activation of transcription by the proteasome
Genes involved in unsaturated fatty acid synthesis in the yeast Saccharomyces cerevisiae appear to be regulated by a mechanism similar to the SREBPs [6] . The yeast protein Spt23p is a transcriptional activator of OLE1 [9] , which encodes a key enzyme in the biosynthesis of unsaturated fatty acids such as oleic and palmitoleic acid. This transcription factor is an integral membrane protein of the ER, which in yeast is continuous with the nuclear envelope. In response to the requirement for more unsaturated fatty acids, Spt23p is cleaved, releasing the amino-terminal transcriptional activation domain, which translocates to the nucleus to activate transcription of OLE1 and other target genes. From our knowledge of SREBP regulation in mammals, one might anticipate a specific protease would be responsible for the cleavage of Spt23p. However, an unexpected wrinkle recently emerged from an elegant genetic study by Hoppe et al. [6] that implicates the proteasome in the role of the specific protease.
The proteasome is a protein complex that degrades a multitude of proteins, usually upon their misfolding or aggregation. Proteins destined for degradation by the proteasome are ubiquitinated by a set of enzymes designated E1, E2 and E3. E1 activates a ubiquitin moiety that is subsequently transferred to the E3 ubiquitin-protein ligase via the ubiquitin-carrier protein E2. E3 then directly transfers the ubiquitin moiety to the protein intended for degradation. There are a number of different E3 enzymes in yeast, each thought to interact with a subset of protein targets with similar structural motifs. The E3s therefore bestow a certain degree of specificity to an otherwise general degradation machinery.
Hoppe et al. [6] demonstrated that the E3 ubiquitin-protein ligase Rsp5p is required for the proteolytic activation of Spt23p. In fact, Rsp5p contains a C2 domain, which in other proteins mediates interactions with phospholipids [10] . Spt23p is subsequently endoproteolytically cleaved by the proteasome in a reaction that degrades only the carboxy-terminal domain, releasing the intact amino-terminal transcriptional activation domain. This domain can then translocate to the nucleus, where it activates transcription.
The proteasome normally degrades its substrates to small oligopeptides, and it is unusual for the proteasome to leave portions of a substrate protein intact. Spt23p is the first yeast protein shown to be only partially proteolyzed by the proteasome. Escape from complete proteasome degradation has, however, been seen with a few other proteins in other species [11] [12] [13] . The best understood example is that of the mammalian transcription factor NFκB. The proteasome plays two distinct roles in the activation of NFκB. First, it degrades a cytoplasmic inhibitor called IκB, which sequesters NFκB in the cytosol in unactivated cells. Second, the proteasome is needed to make the active form of NFκB from its primary translation product. NFκB is a soluble protein synthesized as a precursor (p105) and proteolyzed by the proteasome, generating an amino-terminal transcriptionally active fragment (p50). It is still not fully understood how NFκB avoids complete degradation by the proteasome [14] , but a glycine-rich region in NFκB has been reported to function as a 'stop-processing' signal [15] .
Regulation by unsaturated fatty acids
The balance between sterol levels and the length and saturation of fatty acids in the phospholipids to a large degree determines a membrane's fluidity and thickness: more unsaturated fatty acids result in a more fluid membrane. Spt23p cleavage, and thus OLE1 transcription, is induced by the need for more unsaturated fatty acids [6] . In accord with this relationship, the unsaturated fatty acids palmitoleic acid (16:1), linoleic acid (18:2) and linolenic acid (18:3) block the processing of Spt23p. Because the transmembrane domain of Spt23p is necessary for cleavage, Hoppe et al. [6] suggest that Spt23p processing may be regulated by physical characteristics of the membrane in which it resides. These characteristics may be sensed by the Spt23p precursor directly, by an interacting protein that regulates the interaction of Spt23p with the Rsp5p ubiqiutin ligase, or by Rsp5p itself, perhaps through its C2 domain.
Mga2p, another transcriptional activator of OLE1, is homologous to Spt23p, and appears to be regulated in a similar manner but in response to different signals from those regulating Spt23p [6] . The processing of Mga2p does not seem to be influenced by unsaturated fatty acids. This lack of an effect on Mga2p is notable, because Mga2p is able to activate OLE1 transcription independently of Spt23p, and it appears to be activated by the same proteasome-dependent activation mechanism that activates Spt23p. It would appear that yeast can regulate unsaturated fatty acid levels in response to several different cues using the same general activation machinery.
A clue to how Mga2p activation of OLE1 is regulated comes from studies of the unfolded protein response. The unfolded protein response is a regulon that responds to the burden of unfolded proteins in the ER. This response is known to regulate synthesis of the hydrophilic headgroups of phospholipids through the inositol response [16] . Interestingly, transcription of MGA2 is also regulated by the unfolded protein response [17] , and Mga2p would in turn presumably affect the degree of saturation of the fatty acid component of phospholipids.
Given the influence membrane characteristics have on activation of both yeast Spt23p and the mammalian SREBPs, it is clear that the membrane attachment of these transcription factors serves both to sequester them away from the nucleus when they are not needed, and to provide a direct way of regulating their activity. Although there are significant differences in the details of how this regulation is achieved, the general mechanism for sterol regulation in mammalian cells seems to be repeated in unsaturated fatty acid regulation in yeast. It remains to be seen if this general theme is conserved in the transcriptional regulation of sterols in yeast.
